| 0.66 0.021 (3.22%) | 08-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.9 | 1-year : | 1.02 |
| Resists | First : | 0.77 | Second : | 0.87 |
| Pivot price | 0.67  |
|||
| Supports | First : | 0.61 | Second : | 0.51 |
| MAs | MA(5) : | 0.64 |
MA(20) : | 0.68 |
| MA(100) : | 0.86 |
MA(250) : | 1.92 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 21.5 |
D(3) : | 16.8 |
| RSI | RSI(14): 42.5 |
|||
| 52-week | High : | 4.34 | Low : | 0.61 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ DH ] has closed above bottom band by 35.3%. Bollinger Bands are 43.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.71 - 0.71 | 0.71 - 0.71 |
| Low: | 0.62 - 0.63 | 0.63 - 0.63 |
| Close: | 0.65 - 0.66 | 0.66 - 0.66 |
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Tue, 18 Aug 2026
Definitive Healthcare (DH) Q2 2026 Earnings Call - AOL.com
Tue, 11 Aug 2026
Definitive Healthcare Corp. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:DH) 2026-08-11 - Seeking Alpha
Tue, 11 Aug 2026
Definitive Healthcare Corp. Stock 12‑Month Price Target Cut to $1.7, Implies 143% Upside - tradingview.com
Mon, 10 Aug 2026
Definitive Healthcare Launches Turbo AI Healthcare Intelligence Platform - Stock Titan
Mon, 10 Aug 2026
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 106 (M) |
| Shares Float | 36 (M) |
| Held by Insiders | 3.7 (%) |
| Held by Institutions | 84.1 (%) |
| Shares Short | 2,040 (K) |
| Shares Short P.Month | 2,640 (K) |
| EPS | -1.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.38 |
| Profit Margin | -71.5 % |
| Operating Margin | -8.7 % |
| Return on Assets (ttm) | -1.8 % |
| Return on Equity (ttm) | -75.5 % |
| Qtrly Rev. Growth | -5.5 % |
| Gross Profit (p.s.) | 1.9 |
| Sales Per Share | 2.25 |
| EBITDA (p.s.) | 0.35 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 39 (M) |
| Levered Free Cash Flow | 57 (M) |
| PE Ratio | -0.4 |
| PEG Ratio | 0 |
| Price to Book value | 0.47 |
| Price to Sales | 0.29 |
| Price to Cash Flow | 1.77 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|